Roumell Sells a Small Amount of Transcept Pharmaceuticals

Jim Roumell‘s Roumell Asset Management reported reducing its position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT) to some 2.3 million shares. According to a new Form 4, Roumell sold 7,020 shares in four transactions, with the price varying between $3.65 and $3.85 apiece.

James Roumell

Disclosure: none